Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

IsraelRecruitingPHASE3

Conditions

Amyotrophic Lateral Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

California Pacific Medical Center, San Francisco, California, United States
Contact: Study coordinator (Christie Linh) · clinicalresearch@sutterhealth.org
Mayo Clinic, Jacksonville, Florida, United States
University of South Florida, Tampa, Florida, United States
Contact: Study coordinator (Jessica Shaw) · jessshaw@usf.edu · (813) 974-9413
Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Wanda Sanchez) · wanda.sanchez@emory.edu · 404-727-1273
Northwestern University, Chicago, Illinois, United States
Contact: Study coordinator (Candace James) · candace.james@northwestern.edu
University of Kansas, Fairway, Kansas, United States
Study coordinator · nstaudenmier@kumc.edu
Sean M. Healey & AMG Center for ALS, Boston, Massachusetts, United States
Contact: Study coordinator (Julia Stein) · mghpridopidinephase3healey@mgb.org · 617-726-1398
Washington University, St Louis, Missouri, United States
Study coordinator · als@wustl.edu · 844-257-2273
Somnos Clinical Research, Lincoln, Nebraska, United States
Study coordinator · desi@somnos.com · 402-770-7403
Study coordinator · wendy@somnos.com
Eleanor and Lou Gehrig ALS Center at Columbia University, New York, New York, United States
Contact: Study coordinator (Arish Jamil) · aj3098@cumc.columbia.edu
Neuroscience Department at LKSM at Temple University, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Kathleen Hatala) · Kathleen.hatala@tuhs.temple.edu · 215-707-4171
Contact: Study coordinator (Christine Barr) · Christine.barr@tuhs.temple.edu · 215-707-5440
Texas Neurology, Dallas, Texas, United States
Study coordinator · sdoyle@texasneurology.com · 214-827-3610
Baylor College of Medicine; McNair Medical Campus, Houston, Texas, United States
Contact: Study coordinator (Jorge E. Zaragoza Zapiain) · Jorge.ZaragozaZapiain@bcm.edu · 713-798-0106
Swedish Medical Center, Seattle, Washington, United States
Contact: Study coordinator (Laura Johnson) · Laura.Johnson3@Swedish.org · 206-320-7115
University of Washington, Seattle, Washington, United States
UZ Leuven, Leuven, Belgium
Contact: Study coordinator (Evi Parente) · 0032 16 338668
Contact: Study coordinator (Ann D'hondt) · 0032 16 37 75 77
Genge Partners, Montreal, Quebec, Canada
Study coordinator · KMunoz@gengepartners.com
Hospitalier Pitié-Salpêtrière, Paris, France
ALS outpatient department at Charité - university medicine Berlin, Berlin, Germany
Contact: Study coordinator (Birgit Koch) · Birgit.koch@charite.de
ALS Clinic Bonn University, Bonn, Germany
Study coordinator · motoneuron-ambulanz@ukbonn.de
University Hospital Jena, Jena, Germany
Study coordinator · neurologie-studien@med.uni-jena.de
University of Ulm, Ulm, Germany
Hadassah Medical Center, Jerusalem, Israel
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Centro Clinico NEMO Fondazione Serena Onlus - ASST Niguarda Hospital, Milan, Italy
Istituto Auxologico Italiano Ospedale San Luca, Milan, Italy
Contact: Study coordinator (Nicola Ticozzi) · n.ticozzi@auxologico.it · 390261911
Contact: Study coordinator (Luca Grappiolo) · luca.grappiolo@auxologico.it · 390261911
UMC Utrecht, Utrecht, Netherlands
Centrum Medyczne Neuromed, Bydgoszcz, Poland
Contact: Study coordinator (Dr. Paweł Lisewski) · 0048 513904844
Linden sp. z o. o. sp. k., Krakow, Poland
Contact: Study coordinator (Anna Soltysiak) · anna.soltysiak@cmlinden.com
City Clinic Research Sp. z o.o., Warsaw, Poland
Contact: Study coordinator (Magdalena Kuźma-Kozakiewicz) · info@cityclinic.pl
Hospital Universitario La Paz - Carlos III, Madrid, Spain
Study coordinator · ela.hciii@salud.madrid.org
Clinical Hospital Santiago de Compostela, Santiago de Compostela, Spain
Hospital Universitari i Politècnic La Fe, Valencia, Spain
Contact: Study coordinator (Juan F Vázquez Costa) · ensayos_clinicos_ela@iislafe.es
Studieenheten Akademiskt specialistcentrum, Stockholm, Sweden
Contact: Study coordinator (Caroline Ingre) · studieenheten.slso@regionstockholm.se
Umeå University Hospital, Umeå, Sweden
Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of COYA 302 for the Treatment of ALS

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Los Angeles, United States

Ultra-high-caloric, Fatty Diet in ALS

Amyotrophic Lateral Sclerosis

Abroad (travel likely)Recruiting

Aachen, Germany · Berlin, Germany

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Frontotemporal Dementia · Amyotrophic Lateral Sclerosis · Progressive Supranuclear Palsy

Abroad (travel likely)Recruiting

Bethesda, United States

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Tetraplegia/Tetraparesis · Amyotrophic Lateral Sclerosis (ALS) · Muscular Disorders, Atrophic

Abroad (travel likely)Recruiting

Baltimore, United States